


Pharmaceuticals | Small Cap
Biofil Chemicals & Pharmaceuticals Ltd operates within the Pharmaceuticals & Biotechnology sector. The company exhibits strengths in solvency and growth, driven by low debt levels and robust revenue and asset expansion. However, profitability metrics, such as gross profit margin, return on capital employed, return on equity and return on assets needs improvement. Efficiency ratios also indicate potential challenges in managing inventory and receivables. While the company's coverage ratios are strong, financial ratios suggest concerns with earnings per share and book value. The company demonstrates good revenue growth and management of its assets, but struggles in converting sales into profit and also needs to enhance profitability and efficiency to ensure sustainable financial health.
Biofil Chemicals & Pharmaceuticals Ltd operates within the Pharmaceuticals & Biotechnology sector. The company exhibits strengths in solvency and growth, driven by low debt levels and robust revenue and asset expansion. However, profitability metrics, such as gross profit margin, return on capital employed, return on equity and return on assets needs improvement. Efficiency ratios also indicate potential challenges in managing inventory and receivables. While the company's coverage ratios are strong, financial ratios suggest concerns with earnings per share and book value. The company demonstrates good revenue growth and management of its assets, but struggles in converting sales into profit and also needs to enhance profitability and efficiency to ensure sustainable financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
19.61
Industry Median
19.41
Small Cap Median
18.08
P/E RATIO
100.94
P/B RATIO
2.62
Industry Median
1.98
Small Cap Median
2.03
P/S RATIO
N/A
Industry Median
2.06
Small Cap Median
1.64
Others
PEG RATIO
-7.06
EV/EBITDA RATIO
48.23
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹34.32 as on Feb 20, 2026.
The company has mixed performance in growth metrics. Strong revenue and asset growth rates indicate good expansion. However, declines in operating profit and EPS growth suggest that profitability is not keeping pace with revenue. This could be due to rising costs or reduced efficiency. While the company is expanding, it needs to focus on improving profitability to ensure sustainable growth. However, high asset growth might be due to strategic investments in R&D or infrastructure, which could yield long-term benefits.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Growth Rate | -12.09 | -16.88 | -12.78 | -30.17 | 4.94 |
| Earnings Per Share (EPS) Growth | 2.7 | -43.42 | -20.93 | 29.41 | -22.73 |
| Asset Growth Rate | N/A | -43.65 | 67.65 | 49.94 | 8.22 |
| Net Income Growth Rate | N/A | N/A | N/A | N/A | N/A |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Biofil Chemicals & Pharmaceuticals Ltd | 4.22 | 100.94 | Neutral | 0.85 | 1.71 | 0.56 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT